Very Rare Liver Tumor: PEComa Case Report with and a Review of Literature

Abstract

Perivascular epithelioid cell tumors (PEComas) are very rare mesenchymal tumors. In addition to being rare in general, they are even rarer in the liver. There are various subtypes and there is only one case of liver PEComa reported in the clear cell type in the literature to date. We present the second clear cell type liver PEComa in this case by reviewing the literature data. The hypodense, smooth-edged, ovoid lesion was detected on computed tomography (CT) for performing abdominal pain in a 41-year-old female patient. Magnetic resonance imaging (MRI) was then performed for lesion characterization. The lesion was hypointense on T1-weighted imaging (T1WI), hyperintense on T2-weighted imaging (T2WI). In dynamic phases, it showed marked enhancement on the arterial phase and capsular enhancement with central washout on the portal and late venous phases. The posterior branch of the right portal vein extended into the mass. The lesion was excised and the pathological result was epithelioid clear cell subtype of PEComa. Although the imaging findings are generally nonspecific and certain diagnosis is made histopathologically, radiologists should consider PEComa in the differential diagnosis in the presence of intensely enhanced lesion on the right lobe in female patients. Also, the “large vessel sign” may help in the diagnosis.

Keywords

perivascular epithelioid cell tumors liver - computer tomography - magnetic resonance imaging

Introduction

Perivascular epithelioid cell tumors (PEComas) are very rare mesenchymal tumors. PEComas are composed of distinctive cells that show association with blood vessel walls and usually express melanocytic and smooth-muscle markers.[1] The PEComa tumor group includes tumors such as angiomyolipoma (AML), clear cell “sugar” tumor, lymphangioleiomyomatosis (LAM), and clear cell myomelanocytic tumor (CCMMT). They are far more common among women.[2]

PEComas show a wide anatomical distribution, but most arise from the kidney, retroperitoneum, uterus, and pancreas in the abdomen.[1] [3] Liver PEComas are extremely rare. They are usually discovered incidentally and benign in character.[4]

In this study, we aimed to present an incidentally detected liver PEComa and its common radiological features by reviewing the literature data.

Case Report

A 41-year-old female patient had an incidental lesion in the liver on contrast-enhanced abdominal computed tomography (CT) performed for abdominal pain. The hypodense lesion was 35 × 30 mm in size, smooth-edged, and ovoid ([Fig. 1]). Dynamic contrast-enhanced magnetic resonance imaging (MRI) was then performed for lesion characterization. The lesion was hypointense on T1-weighted images (T1WI) and hyperintense on T2-weighted images (T2WI), and there was no signal loss in fat-suppressed sequences ([Fig. 2]) but there was restricted diffusion ([Fig. 3]). In dynamic phases, the lesion showed marked enhancement in the arterial phase. Capsular enhancement with central washout was detected in the portal vein and late venous phases. In the hepatobiliary phase examination, the lesion was found to be hypointense ([Fig. 4]). In the liver parenchyma, there was no finding in favor of chronic liver parenchymal disease and it was remarkable that the posterior branch of the right portal vein extended into the mass ([Fig. 5]). The patient's hematological and biochemical parameters and tumor markers were within normal limits. With the preliminary diagnosis of hypervascular liver mass, the lesion was excised. Pathologically, HMB45, actin, vimentin, and melanin were positive. Findings were consistent with PEComa and epithelioid clear cell tumor subtype. So far, the patient has been followed for 66 months with no local recurrence or distant metastasis.

Fig. 1 Contrast-enhanced computed tomography (CT) image showing an ovoid, smoothly marginated, hypodense mass on the right lobe of the liver. Arrow is showing the lesion.

Fig. 2 (A) Axial T2-weighted images showing the high-signal mass lesion in the right of liver. (B) Axial fat-suppressed T2-weighted images not showing the suppression of the signal. Arrows are showing the lesion.

Fig. 3 Diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI). (A) DWI and (B) apparent diffusion coefficient (ADC) map: a significant restricted diffusivity of the liver mass (white arrow in A and black arrow in B) is detected. Arrows are showing the lesion.

Fig. 4 Perivascular epithelioid cell tumor (PEComa) in segment VII demonstrating (A) bright enhancement at the arterial phase, (B) capsular enhancement at the portal phase, and (C) no enhancement at the hepatobiliary phase. Arrows are showing the lesion.

Fig. 5 A portal venous phase magnetic resonance (MR) scan demonstrating a vessel with direct contact to the right main portal vein (PV) and mass. Arrow is showing the vessel.

Discussion

PEComa can originate in almost any part of the body. Liver PEComa was classified by the World Health Organization (WHO) in 2002 as a mesenchymal tumor of the liver.[5] AML is the most common PEComa tumor in the liver and kidney. In our case, PEComa was a subtype of clear cell tumor, which is very rare in the liver PEComa tumor family. Clear cell PEComa is more common in middle-aged women and in the lung.[6] Extrapulmonary clear cell PEComas have been described in various organs such as the uterus and pancreas.[7] [8] We found only one case of clear cell type PEComa in liver parenchyma in the literature.[6] In this case, the tumor was observed in the right lobe and in a middle-aged female patient similar to our case.

Up to now 30 liver non-AML PEComa cases have been reported in the literature ([Table 1]). The mean age was calculated as 49.2 (range: 32–75) years. Six of the patients were males, and 24 were females. The average tumor size was about 5.9 cm (range: 0.8–17). It can be stated that liver PEComas are seen in a wide range of sizes. Nine of 30 masses in the literature were incidentally detected. The mass was detected in the right lobe in 19 cases, in the left lobe in 9 cases, and in both lobes in 2 cases. Histopathologically, only two cases were reported as malignant. According to these findings, PEComas are generally benign. They are detected as incidental. Clinical symptoms are nonspecific findings such as abdominal pain, swelling, and nausea. A mass was detected incidentally in our case. As in our case, PEComas occur more commonly in middle-aged female patients and in the right lobe.

Table 1 Review of the liver PEComa cases reported in the literature

Study	Age (y)	Gender	Hepatic lobe	Size (cm)	Symptom/finding	Histologic	Malign/benign
Fang et al[22]	56	F	Left	5.1	Abdominal pain	PEComa	Benign
Fang et al[22]	63	F	Left	None	Abdominal pain	PEComa	Benign
Svajdler et al[23]	55	F	Left	3.5	None	PEComa	Benign
Larbcharoensub et al[24]	31	F	Right	1.8	Abdominal pain	CCMMT	Benign
Zimmermann et al[17]	53	M	Right	8	Abdominal pain	PEComa	Benign
Paiva et al[25]	51	F	Left	0.8	Abdominal pain, weight loss	PEComa	Benign
Strzelczyk et al[6]	50	F	Right	17	Abdominal pain	Clear cell sugar PEComa	Benign
Priola et al[26]	36	F	Left	11	Abdominal pain	PEComa	Benign
Jafari et al[27]	53	F	Left	7.5	Hemorrhage	PEComa	Malign
Cheung et al[20]	53	F	Right	10	Abdominal pain	PEComa	Benign
Zhao et al[12]	50	M	Right	10	Abdominal pain	PEComa	Benign
Yu and Tang[28]	41	F	Right	2.2	Abdominal pain + fever	PEComa	Benign
Patra et al[29]	50	F	Right	24	Abdominal pain	Pigmented PEComa	Benign
Shen et al[9]	55	M	Right	1.6	Incidental	PEComa	Benign
Khaja et al[30]	51	M	Right	None	Incidental	PEComa	Benign
Liu et al[13]	25	F	Right	1.8	Incidental	PEComa	Benign
Ameurtesse et al[10]	63	F	Left	8	Abdominal pain	PEComa	Benign
Khan et al[15]	61	M	Right	7	Incidental	PEComa	Benign
Abhirup et al[11]	72	F	Both	10	Abdominal pain	PEComa	Malign
Arribas Jurado et al[31]	45	F	Right	4	Abdominal pain	PEComa	Benign
Schaeffer and Poulin[4]	49	F	Left	2.9	Abdominal pain	PEComa	Benign
Son et al[1]	56	F	Right	4.5	Incidental	PEComa	Benign
Kirnap et al[32]	22	F	Right	16	Incidental	PEComa	Benign
Voulgari et al[33]	47	F	Both	7	Abdominal pain	PEComa	Benign
Matrood et al[34]	51	F	Right	2	Incidental	PEComa	Benign
Kou et al[18]	37	M	Right	2.5	Abdominal pain	PEComa	Malign
Kou et al[18]	70	F	Left	5	Incidental	PEComa	Benign
Kou et al[18]	30	F	Right	5	Abdominal pain	PEComa	Benign
Harwal et al[19]	27	F	Right	10	Abdominal pain	PEComa	Benign
Perán Fernández et al[35]	74	F	Right	3.5	Incidental	PEComa	Benign

Abbreviations: CCMMT, clear cell myomelanocytic tumor; PEComa, perivascular epithelioid cell tumor.

PEComas have nonspecific CT and ultrasound findings. In MRI, they show high signal intensity on T2WI and low signal intensity on T1WI.[1] [9] [10] [11] [12] [13] Heterogeneous enhancement in the arterial phase was noted in the literature.[9] [14] [15] [16] [17] Heterogeneous contrast enhancement may vary depending on the amount of fat and vascular and muscle cells it contains. The presence of washout in the portal and venous phases raises suspicion for hepatocellular carcinoma (HCC).[4] [8] [17] [18] It can also restrict diffusion like HCC.[1] [10] Hypervascular liver tumors such as focal nodular hyperplasia, hemangioma, and adenoma are included in the differential diagnosis. As the name implies, PEComas have abundant vascularity in or around the tumors. Therefore, they may show intense contrast enhancement and close vessel relationship, especially in contrast phases.[19] [20] In the study of Gao et al, “large blood vessel” was observed in approximately 80% of liver PEComas.[21] In our case, the mass was observed to be associated with the right portal vein branch ([Fig. 5]). Vascular feeding of PEComas may be helpful in the differentiation of HCC. In HCC, it may be associated with arteries and in PEComas with veins.[1]

The definite diagnosis of PEComa is made histopathologically. Its histopathological features are diagnostic, and as its name signifies, it includes a group of cells with positive perivascularly located myocyte and melanocytic markers.

The appropriate treatment option is surgery. They usually have a benign course and rarely relapse-metastasize.

Conclusion

The incidence of PEComas is increasing due to the increase in imaging. Although the imaging findings are generally nonspecific, radiologists should consider PEComa in the differential diagnosis in the presence of intensely enhanced lesion in the right lobe in a female patient. Also, the “large vessel sign” may help in the diagnosis.

Conflict of Interest

None declared.

Author Contributions

C.Y. was responsible for the conceptualization, data curation, investigation, and writing the original draft. E.G. was responsible for formal analysis, investigation, review, supervision, and editing.

Consent for Publication

Informed consent was obtained from the patient prior to the study.

• References

• 1 Son H-J, Kang DW, Kim JH, Han HY, Lee MK. Hepatic perivascular epithelioid cell tumor (PEComa): a case report with a review of literatures. Clin Mol Hepatol 2017; 23 (01) 80-86
• 2 Hornick JL, Fletcher CDM. PEComa: what do we know so far?. Histopathology 2006; 48 (01) 75-82
• 3 Musella A, De Felice F, Kyriacou AK. et al. Perivascular epithelioid cell neoplasm (PEComa) of the uterus: a systematic review. Int J Surg 2015; 19: 1-5
• 4 Schaeffer DF, Poulin MP. Primary hepatic perivascular epithelioid tumor (PEComa). Ann Hepatol 2016; 15 (03) 436-437
• 5 Folpe AL, Kwiatkowski DJ. Perivascular epithelioid cell neoplasms: pathology and pathogenesis. Hum Pathol 2010; 41 (01) 1-15
• 6 Strzelczyk JM, Durczynski A, Szymanski D, Jablkowski M, Dworniak D, Sporny S. Primary perivascular epithelioid cell tumor (PEComa) of the liver: report of a case. Surg Today 2009; 39 (10) 916-921
• 7 Martignoni G, Pea M, Reghellin D, Zamboni G, Bonetti F. PEComas: the past, the present and the future. Virchows Arch 2008; 452 (02) 119-132
• 8 Krawczyk M, Ziarkiewicz-Wróblewska B, Wróblewski T. et al. PEComa: a rare liver tumor. J Clin Med 2021; 10 (08) 1756
• 9 Shen HQ, Chen DF, Sun XH. et al. MRI diagnosis of perivascular epithelioid cell tumor (PEComa) of the liver. Rom J Morphol Embryol 2013; 54 (03) 643-647
• 10 Ameurtesse H, Chbani L, Bennani A. et al. Primary perivascular epithelioid cell tumor of the liver: new case report and literature review. Diagn Pathol 2014; 9: 149
• 11 Abhirup B, Kaushal K, Sanket M, Ganesh N. Malignant hepatic perivascular epithelioid cell tumor (PEComa): case report and a brief review. J Egypt Natl Canc Inst 2015; 27 (04) 239-242
• 12 Zhao LJ, Yang YJ, Wu H, Huang SM, Liu K. Perivascular epithelioid cell tumor of the liver: a case report and literature review. Eur Rev Med Pharmacol Sci 2013; 17 (12) 1665-1668
• 13 Liu D, Shi D, Xu Y, Cao L. Management of perivascular epithelioid cell tumor of the liver: a case report and review of the literature. Oncol Lett 2014; 7 (01) 148-152
• 14 Zhuang Y, Zeng Y, Ying L, Song C. Epithelioid angiomyolipoma of the liver: a case report. Asian J Surg 2023; 46 (03) 1376-1377
• 15 Khan HM, Katz SC, Libbey NP, Somasundar PS. Hepatic PEComa: a potential pitfall in the evaluation of hepatic neoplasms. BMJ Case Rep 2014; 2014: bcr2014204122
• 16 Wang S, Xia H, Liu X, Liu Y, Lou C. Hepatic epithelioid angiomyolipoma mimicking hepatocellular carcinoma on MR and ¹⁸F-FDG PET/CT imaging: a case report and literature review. Hell J Nucl Med 2022; 25 (02) 205-209
• 17 Zimmermann A, von der Brelie C, Berger B, Kappeler A, Candinas D. Primary perivascular epithelioid cell tumor of the liver not related to hepatic ligaments: hepatic PEComa as an emerging entity. Histol Histopathol 2008; 23 (10) 1185-1193
• 18 Kou YQ, Yang YP, Ye WX, Yuan WN, Du SS, Nie B. Perivascular epithelioid cell tumors of the liver misdiagnosed as hepatocellular carcinoma: three case reports. World J Clin Cases 2023; 11 (02) 426-433
• 19 Harwal R, Joseph Rosemary LJ, Raju P, Chidambaranathan S, Bharathi Vidya Jayanthi J, Obla Lakshmanamoorthy NB. Hepatic perivascular epithelioid cell tumor mimicking hepatocellular carcinoma. ACG Case Rep J 2023; 10 (01) e00962
• 20 Cheung TT, Trendell-Smith N, Poon RT. Primary perivascular epithelioid cell tumour (PEComa) of the liver. BMJ Case Rep 2013; 2013: bcr2013008706
• 21 Gao X, Tang H, Wang J. et al. Specific imaging features indicate the clinical features of patients with hepatic perivascular epithelioid cell tumor by comparative analysis of CT and ultrasound imaging. Front Oncol 2022; 12: 908189
• 22 Fang SH, Zhou LN, Jin M, Hu JB. Perivascular epithelioid cell tumor of the liver: a report of two cases and review of the literature. World J Gastroenterol 2007; 13 (41) 5537-5539
• 23 Svajdler M, Bohus P, Goc V, Tkácová V. Perivascular epithelioid cell tumor (PEComa) of the liver: a case report and review of the literature. Cesk Patol 2007; 43 (01) 18-22
• 24 Larbcharoensub N, Karnsombut P, Jatchavala J, Wasutit Y, Nitiyanant P. Primary hepatic clear cell myomelanocytic tumor. Case report and review of the literature. Acta Pathol Microbiol Scand Suppl 2007; 115 (12) 1454-1459
• 25 Paiva CE, Moraes Neto FA, Agaimy A, Custodio Domingues MA, Rogatto SR. Perivascular epithelioid cell tumor of the liver coexisting with a gastrointestinal stromal tumor. World J Gastroenterol 2008; 14 (05) 800-802
• 26 Priola AM, Priola SM, Cataldi A, Marci V, Fava C. Acute abdomen as an unusual presentation of hepatic PEComa. A case report. Tumori 2009; 95 (01) 123-128
• 27 Jafari A, Fischer HP, von Websky M, Hong GS, Kalff JC, Manekeller S. Primary perivascular epitheloid cell tumour (PEComa) of the liver: case report and review of the literature. Z Gastroenterol 2013; 51 (09) 1096-1100
• 28 Yu D, Tang S. Hepatic perivascular epithelioid cell tumor: a case report and review of the literature. Intern Med 2013; 52 (12) 1333-1336
• 29 Patra S, Vij M, Kota V, Kancherla R, Rela M. Pigmented perivascular epithelioid cell tumor of the liver: report of a rare case with brief review of literature. J Cancer Res Ther 2013; 9 (02) 305-307
• 30 Khaja F, Carilli A, Baidas S, Sriharan A, Norford S. PEComa: a perivascular epithelioid cell tumor in the liver: a case report and review of the literature. Case Rep Med 2013; 2013: 904126
• 31 Arribas Jurado M, Revollo I, Rubio Fernández A, Galeano Díaz F, Blanco Fernández G. Primary liver PEComa. Cir Esp 2015; 93 (09) 600-601
• 32 Kirnap M, Ozgun G, Moray G, Haberal M. Perivascular epithelioid cell tumor outgrowth from the liver. Int J Surg Case Rep 2018; 53: 295-298
• 33 Voulgari PV, Tatsi V, Milionis HJ, Goussia A, Xydis V, Glantzounis GK. Liver perivascular epithelioid cell tumor in a patient with systemic lupus erythematosus. Int J Surg Case Rep 2018; 53: 193-195
• 34 Matrood S, Görg C, Safai Zadeh E, Alhyari A. Hepatic perivascular epithelioid cell tumor (PEComa): contrast-enhanced ultrasound (CEUS) characteristics: a case report and literature review. Clin J Gastroenterol 2023; 16 (03) 444-449
• 35 Perán Fernández C, de Paco Navaro Á, Castañer Ramón-Llin J, Bertelli Puche J, Sánchez Espinosa A. Perivascular epithelioid cell tumor (PEComa) of the liver. An extremely rare diagnosis. Rev Esp Enferm Dig 2023; 115 (06) 348-349

Publikationsverlauf

Artikel online veröffentlicht:
27. Oktober 2023